Amgen and Teva Pharmaceuticals Industries have been granted permission for an expedited appeal in an antitrust case related to Amgen’s Sensipar, a calcium reducer, after a lower court decision.
According to a memorandum by Judge Colm F. Connolly in the US District Court for the District of Delaware, pharmaceutical companies have the right to appeal a decision if he finds that he does not have the authority to allow an interlocutory appeal of a previous judge’s ruling.
Related: Warren Sends Letter To FTC Over Amgen & Indivior Deals
There is “substantial ground for difference of opinion” about whether a judge can certify for interlocutory appeal another judge’s order in the same case, Connolly said.
